Because PKC inhibition induced B-ALL sensitization to DEXA [16], VNC, and MTX (this study), through a decreased cell-adhesion-mediated mechanism, we evaluated drug sensitization in the presence of the BAY inhibitor of NF-κB. The gene discussed is PRRT2; the disease is precursor B-cell acute lymphoblastic leukemia.